Journal of Cancer Metastasis and Treatment

Editorial Board

Honorary Editors-in-Chief

Dai-Ming Fan

State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xi'an, Shaanxi, China.

Research Interests: Identification and application of gastric cancer associated antigens, multi-drug resistance of gastric cancer, immunogenetics and pathogenesis of gastric cancer
Yan Sun

Academician of Chinese Society of Engineering, Beijing, China.

Research Interests: Clinical oncology, non-small cell lung cancer, breast cancer, target therapy

Editor-in-Chief

Lucio Miele

lmiele@lsuhsc.edu

Department of Genetics, School of Medicine, LSU Health Sciences Center, New Orleans, LA, USA.

Research Interests: Cancer stem cell-regulatory genes, GWAS, transcriptome, cancer-associated genes, genomic biomarkers, cancer health disparities
Contributions:
Introduction to Volume 1 Issue 2 of Journal of Cancer Metastasis and Treatment

Neuroendocrine tumors: current therapies, notch signaling, and cancer stem cells

Associate Editors

Alessandro Antonelli

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Research Interests: Thyroid endocrinology, thyroid cancer, new treatment of thyroid cancer
Laurence H. Baker

Departments of Internal Medicine and Pharmacology, University of Michigan, Ann Arbor, MI, USA.

Research Interests: Sarcoma research, clinical trials, new drug development
Contributions:
Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study
Special Issue:
Soft Tissue Sarcoma - Diagnosis and Treatment
Gary L. Clayman

The Clayman Thyroid Surgery and Thyroid Cancer Center, Tampa, FL, USA.

Research Interests: Surgical management of thyroid cancer, otolaryngology
Pran K. Datta

School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.

Research Interests: Basic and translational oncology, immunohisyochemlstry, genomics, signaling pathway
Massimo Federico

Medical Oncology, CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.

Research Interests: Follicular lymphoma, hodgkin lymphoma, T-cell lymphoma
Alfio Ferlito

Coordinator of the International Head and Neck Scientific Group, Padua, Italy.

Research Interests: Head and neck cancer, clinical practice, teaching and research
Umberto Galderisi

Department of Molecular Biology, Second University of Naples, Naples, Italy.

Research Interests: Basic and applied researches on normal and cancer stem cells, analysis of senescence processes that affect stem cell properties, effect of low dose radiations on the biology of normal and cancer stem cells
Jerome M. Hershman

Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.

Research Interests: Pathogenesis and management of thyroid cancer
Special Issue:
Mechanism and Treatment of Thyroid Cancer
Ciro Isidoro

Department of Health Sciences, Università del Piemonte Orientale "A. Avogadro", Novara, Italy.

Research Interests: Lysosomal proteolysis, pathogenesis of diseases, Cathepsin D, nanobioimaging, autophagy-lysosomal pathway in cancer and in neurodegeneration
Contributions:
Epigenetic control of autophagy in women’s tumors: role of non-coding RNAs
Special Issue:
Papers from the 3rd International Workshop No-Cancer 2018 ---Understanding Cancer Cell Biology to Improve Diagnosis and Therapy
Gopal C. Kundu

KIIT Deemed to be University, Institute of Eminence, Bhubaneswar, India.

Research Interests: Tumor biology, cancer stem cells, tumor-stroma interaction, angiogenesis, cancer therapeutics biomarker development, nanomedicine
JS Miguel

Clinica Universitaria de Navarra, Pamplona, Spain.

Research Interests: Myeloma cell biology, minimal residual disease, proteasome inhibitors, immunomodulatory drugs, histone deacetylases
Yin-Yuan Mo

Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, USA.

Research Interests: MicroRNAs and long non-coding RNA in cancers
Contributions:
Long non-coding RNAs as key regulators of cancer metastasis
Andrea Nicolini

Department of Internal Medicine, University of Pisa, Santa Chiara Hospital, Pisa, Italy.

Research Interests: Breast and gastrointestinal cancer and their metastases, tumour markers, post-operative follow-up, physiopathology, immunology and immunotherapy of cancer, thyroid tumours
Contributions:
Prognostic factors and efficacy of GDP-R therapy in refractory/relapsed diffuse large B-cell lymphomas not eligible for high-dose therapy
Godefridus J. Peters

Laboratory Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.

Research Interests: Pharmacology of anticancer agents, antimetabolites, antifolates, platinum analogs, taxanes, anti-signalling agents, third generation targeted-agents
Contributions:
Gemcitabine followed by radiotherapy in treatment of newly diagnosed high-grade gliomas
Special Issue:
Cancer Pharmacogenomics
John M. Pezzuto

College of Pharmacy and Health Sciences, Western New England University, Springfield, MA, USA.

Research Interests: Natural product drugs, drug discovery and characterization, cancer therapy and chemoprevention
Contributions:
Phytochemicals and cancer chemoprevention
Stephen J. Ralph

School of Medical Science, Griffith Health Institute, Griffith University, Southport, Queensland, Australia.

Research Interests: Melanoma vaccines, metastatic cancers, classification of mitocans, effects of laser irradiation on carcinoma
Domenico Ribatti

Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy.

Research Interests: Angiogenesis in hematological tumors, angiogenesis in hematological tumors, angiogenesis in bone tumors, role of mast cells in tumor angiogenesis, role of chemokines in angiogenesis, role of GM-CSF in angiogenesis, role of PDGF and sugars in angiogenesis, role of transferrin in angiogenesis
Special Issue:
Angiogenesis and Antiangiogenesis in Hematological Malignancies
William P. Schiemann

Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.

Research Interests: TGFβ & cell signaling, breast cancer metastasis & recurrence, metastatic dormancy, breast cancer stem cells, epithelial-mesenchymal transition, tumor heterogeneity, noncoding RNAs, epigenome
Contributions:
TGF-β stimulation of EMT programs elicits non-genomic ER-α activity and anti-estrogen resistance in breast cancer cells

Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution

The lncRNA BORG: a novel inducer of TNBC metastasis, chemoresistance, and disease recurrence

Autophagy in breast cancer metastatic dormancy: tumor suppressing or tumor promoting functions?

Introduction to this special issue “Breast Cancer Metastasis”
Special Issue:
Breast Cancer Metastasis
Hans-Joachim Schmoll

University Hospital Halle (Saale), Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Research Interests: Colorectal cancer, gastrointestinal cancers, genitourinary cancers, germline cancers
Gautam Sethi

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Research Interests: Transcription factors in cancer progression, cell signaling, chemoprevention, pharmaceuticals
Fatih M. Uckun

Vice President, Oncology and Hematology, Worldwide Clinical Trials, Morrisville, NC, USA.

Research Interests: Developmental therapeutics, biopharmaceuticals, oncology, immuno-oncology, infectious diseases, immunology
Special Issue:
Drug Targets and Resistance Mechanisms in Multiple Myeloma

Contemporary Treatment Strategies for Adolescents and Young Adults with Cancer
Jan Baptist Vermorken

Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.

Research Interests: Gynecologic oncology, head and neck oncology, breast and colon cancer
Special Issue:
Research Progress in Head and Neck Cancers
Masayuki Watanabe

Department of Gastroenterological Surgery, Esophageal Cancer Division, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.

Research Interests: Esophageal surgery, esophageal squamous cell carcinoma, noncurative endoscopic resection, upfront esophagectomy, minimally invasive surgery
Contributions:
Recent updates of therapeutic strategy of esophagogastric junction adenocarcinoma

Risk factors and molecular mechanisms of esophageal cancer: differences between the histologic subtypes

Introduction to Volume 1 Issue 3 of Journal of Cancer Metastasis and Treatment

Epigenetic changes in gastrointestinal cancers

Overview of genetic and epigenetic alterationsin the pathogenesis of esophagogastric junctional adenocarcinoma and esophageal adenocarcinoma: recent findings by next generation sequencing

The clinical significance of circulating tumor cells in gastrointestinal cancer

Chronic inflammation and gastrointestinal cancer

MicroRNAs in gastrointestinal cancer: a novel biomarker and its clinical application

Trends in clinical use of targeted therapy for gastrointestinal cancers

Conversion surgery for stage IV gastric cancer

Treatment strategy for metastatic gastric cancer in Japan

Management of metastatic esophagogastric junction adenocarcinoma
Special Issue:
Reviews of Gastric Cancer Metastasis and Treatment

Management of Esophageal Cancer
Yaguang Xi

Department of Genetics, School of Medicine, LSU Health Sciences Center, New Orleans, LA, USA.

Research Interests: Non-coding RNA, tumor metastasis, cancer chemoprevention, immunotherapy, new drug development

European Editor

Klaus Pors

Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, West Yorkshire, UK.

Research Interests: Cytochrome, prostate cancer, drug discovery, target oriented synthesis, medicinal chemistry, diversity-oriented synthesis, small molecules, pharmacoepigenetics, molecular fluorescent probes
Contributions:
Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention

Current challenges and opportunities in treating hypoxic prostate tumors

Expression and regulation of aldehyde dehydrogenases in prostate cancer

Introduction of the special issue “How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?”
Special Issue:
How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?

Editorial Board Members

Prasad S. Adusumilli

Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Research Interests: Lung cancer, esophageal cancer, mediastinal and chest wall tumors, mesothelioma, thymoma, metastatic lung cancers, laparoscopy, lobectomy, bronchoscopy, pleurectomy
Heike Allgayer

Medical Faculty Mannheim, Ruprecht Karls University Heidelberg, Mannheim, Germany.

Research Interests: Tumor progression, invasion and metastasis, molecular determinants of response to novel therapeutics, translational research, molecular staging of cancer
Alexandre Arcaro

Department of Clinical Research, Division of Pediatric Hematology/Oncology, University of Bern, Bern, Switzerland.

Research Interests: Cancer research, oncology, biochemistry, molecular biology, pharmacology
Contributions:
The role of the PI3K/AKT/mTOR pathway in brain tumor metastasis
Ahmad Awada

Department of Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Research Interests: Clinical development of new anticancer agents, cytotoxics, molecular-targeted therapies, immunotherapy
Rossana Berardi

Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.

Research Interests: Non-small cell lung cancer, breast cancer, innovative drugs (target therapy, immunotherapy)
Contributions:
Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase

Electrolyte disorders in cancer patients: a systematic review

Squamous cell carcinoma of the lung: clinical criteria for treatment strategy

Medical therapy for advanced gastro-entero-pancreatic and bronchopulmonary neuroendocrine tumors

Neuroendocrine tumors: a multidisciplinary approach for a complex disease

Immunotherapy in colorectal cancer treatment: actual landscape and future perspectives

Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review
Special Issue:
Neuroendocrine Tumors

Hyponatremia and Cancer
Dominique A. Bonnet

Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London, UK.

Research Interests: Haematopoietic stem cells, blood cancer
Ting-Chang Chang

Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, China.

Research Interests: Molecular markers, gynecologic cancer,endometrial cancer Immune therapy, targeted therapy, recurrent/metastatic gynecologic cancer
Yang-Chao Chen

School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin NT, Hong Kong, China.

Research Interests: Epigenetics in cancer, histone modification particularly methylation, long and short non-coding RNAs, development of novel therapeutics for liver and pancreatic cancer
Chao Cheng

Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.

Research Interests: Cancer systems biology, cancer biomarkers
Contributions:
B cell infiltration is highly associated with prognosis and an immune-infiltrated tumor microenvironment in neuroblastoma
Sheue-Yann Cheng

Gene Regulation Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Research Interests: Thyroid hormone action, thyroid hormone receptors in health and disease, molecular genetics of thyroid cancer, mouse models
Chun Hei Antonio Cheung, PhD

Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, China.

Research Interests: Anti-cancer nanodrug development, cancer drug resistance mechanism, cancer cell autophagy
Contributions:
Introduction to this special issue - “Autophagy and Cancer: current biology and drug development”
Special Issue:
Autophagy and Cancer: current biology and drug development
Ssang-Goo Cho

Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul, South Korea.

Research Interests: Signaling pathways in stem, cancer, and cancer stem cells, molecular mechanism of cellular reprogramming and apoptosis, pancreatic beta-cell, immune-cell, kidney differentiation & organoid culture
Judy Crabtree

Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, USA.

Research Interests: Neuroendocrine and hormone-dependent oncogenesis, cancer stem cells, retinoblastoma binding protein 2
Giuseppe Curigliano

Istituto Europeo di Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico, University of Milano, Milan, Italy.

Research Interests: Early drug development, solid tumours, breast cancer
Contributions:
The use of liquid biopsy in early breast cancer: clinical evidence and future perspectives
Marco Falasca

Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia.

Research Interests: Signalling pathways, intracellular physiological and pathological processes, lysophospholipid lysophosphatidylinositol, phosphoinositide 3-kinase isoforms and phospholipase Cgamma-1, phosphoinositides, ABC transporters, G-protein coupled receptors, cancer progression and cell signalling
Special Issue:
Treatment of Pancreatic Cancer
Mirco Fanelli

Department of Biomolecular Sciences, University of Urbino 'Carlo Bo', Molecular Pathology Lab, Fano, Italy.

Research Interests: Molecular features of gliomas
Contributions:
Real-time quantitative PCR array to study drug-induced changes of gene expression in tumor cell lines
Bingliang Fang

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Research Interests: Innovative anticancer agents, targeted cancer therapy, the mechanisms of action of and/or resistance to anticancer agents, molecular signatures or biomarkers for predicting treatment response or early diagnosis of lung cancers
Contributions:
Introduction to this Special Issue: “Biomarker Discovery and Precision Medicine”
Special Issue:
Biomarker Discovery and Precision Medicine
Maryam K Foroozesh

Department of Chemistry, Xavier University of Louisiana, New Orleans, LA, USA.

Research Interests: Anti-cancer drugs, ceramide, glucosylceramide synthase (GCS), multidrug resistance, p-glycoprotein
Renty B. Franklin

Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, MD, USA.

Research Interests: Prostate cancer and treatment, screening methods for prostate cancer, development and progression of malignancy
Minoru Fukuda

Nagasaki University Clinical Oncology Center, Nagasaki, Japan.

Research Interests: Cell surface carbohydrates, tumor metastasis, neural cell-specific glycans, mucin-type O-glycans, immune cell interactions, carbohydrate-dependent adhesion, helicobacter pylori-mediated inflammation and cancer
Lombardi Giuseppe

Medical Oncology 1 Unit, Veneto Institute of Oncology IOV – IRCCS, Padua, Italy.

Research Interests: Brain tumor, glioblastoma
Contributions:
Gliomatosis cerebri: a monocentric real-life experience
Special Issue:
Primary and Secondary Brain Tumors
Elif Hindié

CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France.

Research Interests: Imaging in endocrinology, TEP imaging in oncology, internal vectored radiation therapy, theranostic applications
Egidio Iorio

Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy.

Research Interests: Leukemic cell proliferation, chemotherapeutic sensitivity, acute myeloid leukemia, molecular and imaging biomarkers, inflammation in oncology
Robert Arthur Kratzke

Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.

Research Interests: Translational mesothelioma and lung cancer research
Contributions:
Covid19 and cancer care: the end of the beginning
Special Issue:
Lung Cancer Metastasis and Treatment under the Epidemic of COVID-19
Ava Kwong

Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Research Interests: Molecular diagnostics for breast cancer, Lung cancer, pancreatic & prostate cancers, hematological malignancy, colon cancer, neurological and Genetic Disorders, cancer stem cells & therapies, early detection markers for breast, lung cancer, molecular targeted therapies of cancer
Xuefen Le Bourhis

INSERM U908 “Cell Plasticity and Cancer”, University of Lille, Villeneuve d’Ascq, France.

Research Interests: Molecular mechanisms of cancer cell plasticity, Breast cancer cells plasticity and metastasis, epigenetics and resistance to treatments for pediatric gliomas, inference, interrogation and engineering of regulatory networksn
Gary Li

Biology and Translational Medicine, RayzeBio, Inc., San Diego, CA, USA.

Research Interests: Targeted therapy, radiation therapy, drug discovery
Contributions:
Opportunities and challenges in developing tissue-agnostic anti-cancer drugs
Ji-Liang Li

Faculty of Medicine and Dentistry, University of Plymouth, Plymouth, UK.

Research Interests: Tumour microenvironment and translational cancer medicine, the combination of cancer target therapy and immunotherapy, tumour associated macrophages, Notch signaling in cancer biology, tumour resistance to target therapy and immunotherapy, hypoxia and angiogenesis pathways in cancer biology, microRNAs in cancer target therapy and immunotherapy, experimental mouse tumour models
Shuen-Kuei Liao

The PhD Program for Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan, China.

Research Interests: Stem cell biology, nanotechnology and tissue engineering
Contributions:
Withaferin A targeting both cancer stem cells and metastatic cancer stem cells in the UP-LN1 carcinoma cell model

Introduction to the Special Issue on Cancer Immunotherapy

Immunotherapy of cancer is a part of biotherapy
Special Issue:
Cancer Immunotherapy
Thomas Liehr

Jena University Hospital, Institute of Human Genetics, Friedrich Schiller University, Jena, Germany.

Research Interests: Inherited and acquired marker and derivative chromosomes, karyotype evolution, uniparental disomy, interphase architecture, probe set-developments
Contributions:
Cryptic NUP214-ABL1 fusion with complex karyotype, episomes and intra-tumor genetic heterogeneity in a T-cell lymphoblastic lymphoma

First molecular cytogenetic characterisation of tracheal squamous cell carcinoma cell line KLN 205
Special Issue:
Genomics Research in Cancer Metastasis and Treatment
Silvana Morello

Department of Pharmaceutical and Biomedical Sciences, University of Salerno, Via Ponte Don Melillo, Fisciano, Salerno, Italy.

Research Interests: Tumor microenvironment, metastatic melanoma, prognostic factor, tumor immunology, mitochondrial metabolism of tumor cells
Contributions:
Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target
Christos A Papadimitriou

Oncology Unit, Second Department of Surgery, “Aretaieion” University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Research Interests: Bone marrow transplantation, gynecologic cancer, breast cancer, lung cancer, GI cancers
Alberto Giuseppe Passi

Department of Medicine and and Surgery (DMC), University of Insubria, Varese, Italy.

Research Interests: Cancer biology, cell migration, collagen, glycosaminoglycans
Leonel Pereira

Department of Life Sciences, University of Coimbra, MARE-Marine and Environmental Sciences Centre, Calçada Martim de Freitas, Coimbra, Portugal.

Research Interests: Phycology, marine biotechnology, biodiversity and taxonomy, bioinformatics and databases, environmental assessment, nutrition and thalassotherapy
DR. PRAVIN POTDAR

Department of Molecular Medicine & Biology, Jaslok Hospital & Research Centre, Mumbai, India.

Research Interests: Molecular diagnostics for breast cancer, Lung cancer, pancreatic & prostate cancers, hematological malignancy, colon cancer, neurological and Genetic Disorders, cancer stem cells & therapies, early detection markers for breast, lung cancer, molecular targeted therapies of cancer
Contributions:
Role of circulating tumor cells in future diagnosis and therapy of cancer

Evaluation of anti-metastatic effect of chitosan nanoparticles on esophageal cancer-associated fibroblasts

Profiling of circulating tumor cells in liquid biopsies from metastatic cancer patients

Circulating tumor cells: hope to diagnose and treat metastatic cancer

Special issue on “Immunotherapy of cancer: future possible therapy for metastatic cancer”
Special Issue:
Immunotherapy Of Cancer: Future Possible Therapy For Metastatic Cancer

Personalized Medicine: Rays Of Hope To Cure Cancer
Luis Raez

Memorial Cancer Institute, Memorial Healthcare System/Florida International University (FIU) Miami, FL, USA.

Research Interests: Lung cancer, head and neck cancers, chemotherapeutic agents and combinations, cancer vaccines
Dong Ren

Department of Orthopaedic Surgery, the First Affiliated Hospital of Sun Yat-sen University, 58# Zhongshan 2rd Road, Guangzhou, China.

Research Interests: Cancer metastasis, cancer dormancy, cancer bone metastasis, breast cancer, prostate cancer
Michele Reni

Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Research Interests: Management of pancreatic adenocarcinoma, gastro-esophageal cancers, central nervous system tumors
Boris Reva

Department of Genetics and Genomic Sciences, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Research Interests: Molecular diagnostics, clinical subtypes and precise medicine of cancer, cancer genomics and immune therapy
Palma Rocchi

Centre National de la Recherche Scientifique, Unités Mixtes de Recherche 7258, Centre de Recherche en Cancérologie de Marseille, Marseille, France.

Research Interests: Hsp27, castration resistant prostate cancer, translationaly controlled tumor protein, novel therapeutic target, nanoparticles technology, prostate cancer therapy
Luis Rodrigo

Gastroenterology Unit, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.

Research Interests: Gastroenterology, hepatology, celiac disease, autoimmune-associated diseases
Special Issue:
Diet, Nutrition, and Cancer Risk
Ahmad R. Safa

Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.

Research Interests: Molecular and biochemical mechanisms of intrinsic and acquired resistance to chemotherapeutic drugs, apoptosis (cell death) in cancer cells, cancer stem cells, drug discovery and development, cancer treatment
Contributions:
Epithelial-mesenchymal transition: a hallmark in pancreatic cancer stem cell migration, metastasis formation, and drug resistance
Lúcio Lara Santos

Department of Surgical Oncology, Portuguese Oncology Institute-Porto (IPO-Porto), Rua Dr. António Bernardino de Almeida, Porto, Portugal.

Research Interests: Surgical oncology and carcinogenesis, experimental pathology and oncology, gastrointestinal, breast cancer, cancers related to infections
Marcus Schmidt

Department of Obstetrics and Gynecology, Comprehensive Cancer Center, University Medical Center Mainz, Langenbeckstr, Mainz, Germany.

Research Interests: Prognostic and predictive factors in breast cancer, immunotherapy in breast cancer, endocrine therapy in breast cancer
Hildegard M. Schuller

Experimental Oncology Laboratory, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA.

Research Interests: Comparative pathology, lung cancer, G protein-coupled receptors, pancreatic cancer, stem cell
Rafat A. Siddiqui

Nutrition Science and Food Chemistry, Agriculture Research Station, Virginia State University, Petersburg, VA, USA.

Research Interests: Dietary fats, molecular nutrition, cancer, fatty acids-polyphenol conjugates
Contributions:
Anti-oxidation properties of leaves, skin, pulp, and seeds extracts from green papaya and their anti-cancer activities in breast cancer cells

Papaya black seeds have beneficial anticancer effects on PC-3 prostate cancer cells
Ira-Ida Skvortsova

Department of Therapeutic Radiology and Oncology, University of Innsbruck, Innsbruck, Austria.

Research Interests: Cancer stem cells, therapy resistance, metastasis development, cancer cell metabolism
Contributions:
Introduction to the Special Issue “Cancer Stem Cells: Impact on Treatment”
Giovanna Tosato

Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Research Interests: Cancer, endothelial cells, vascular biology, hematopoietic stem cell niches
Contributions:
Bone marrow niches in myelodysplastic syndromes
Giovanni Tuccari

Department of Human Pathology "Gaetano Barresi," University of Messina, Messina, Italy.

Research Interests: Triple negative breast carcinomas, prognostic markers, HER2 heterogeneity, human pathology
Contributions:
Uterine large cell neuroendocrine carcinoma with unusual colonic metastasis

Changes in human epidermal growth factor receptor 2 status between primary breast/gastric carcinomas and synchronous metastatic lymph nodes: how can we explain them?
Tamara Lah Turnšek

Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia.

Research Interests: Biology of tumours, stem cells in relation to glioblastoma progression, mesenchymal stem cells as part of tumour micro-environment and as therapeutic agents in regenerative medicine and oncology
Bernard A. M. Van der Zeijst

Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.

Research Interests: Molecular biology, biotechnology, microbiology, vaccines and drug development, immunotherapy and diagnosis of cancer
Yogesh Vashist

Department of Surgery, Asklepios Harzklinik Goslar, Goslar, Germany.

Research Interests: Pancreatic cancer, microRNAs, long noncoding RNA
Paula Videira

Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.

Research Interests: Cancer-associated glycans, dendritic cell-based vaccines, novel biomarkers in cancer
Israel Vlodavsky

Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Research Interests: Cancer metastasis, heparanase, extracellular matrix, tumor microenvironment in cancer progression
Yaoqi Alan Wang

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Research Interests: Cancer biology, glioblastoma, neoplasms, tumors, chemical compounds, glioma, stem cells, pancreatic neoplasms, prostatic neoplasms, adenocarcinoma
Zhou Wang

Shadyside Medical Center, University of Pittsburgh, Pittsburgh, PA, USA.

Research Interests: Androgen action, prostate cancer, benign prostatic hyperplasia
Guofeng Xie

Department of Medicine, Division of Gastroenterology & Hepatology and Program in Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.

Research Interests: Esophageal motility disorders, GERD, colon cancer
Contributions:
The farnesoid X receptor and colon cancer

Muscarinic receptor signaling and colon cancer progression
Ren Xu

Department of Molecular and Biomedical Pharmacology, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.

Research Interests: Microenvironmental signals, breast cancer progression, breast cancer metastasis, ECM microenvironment
Contributions:
Function of cancer cell-derived extracellular matrix in tumor progression
Vladimir Zaichick

Medical Radiological Research Center, Obninsk, Russia.

Research Interests: In vivo and in vitro nuclear analytical methods of chemical element contents measurement in tissues and fluids of human body, age- and gender-dependence of chemical element contents in tissues and fluids, levels of chemical element contents in tissues and fluids as tumour’s markers
Contributions:
Significance of trace element quantities in the prostatic secretion of patients with benign prostatic hyperplasia and prostate cancer

Levels of chemical element contents in thyroid as potential biomarkers for cancer diagnosis (a preliminary study)

Hot Keywords

Editorial Board

Honorary Editors-in-Chief

Editor-in-Chief

Associate Editors

European Editor

Editorial Board Members

JOURNAL OF CANCER METASTASIS AND TREATMENT

Navigation

follow us

OAE Publishing Inc.

OAE JOURNALS

FOLLOW OAE